Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.42 USD | +0.93% | +3.44% | +10.84% |
29/04 | Transcript : Capricor Therapeutics, Inc. - Special Call | |
24/04 | Capricor Therapeutics Gets Another Type-B Meeting With FDA for Duchenne Muscular Dystrophy Investigational Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.84% | 169M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- CAPR Stock
- News Capricor Therapeutics, Inc.
- HC Wainwright Raises Price Target on Capricor Therapeutics to $40 From $18, Keeps Buy Rating